Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Nephron Pharmaceuticals Corporation
- Target Recruit Count
- 116
- Registration Number
- NCT04780984
- Locations
- 🇺🇸
Clinical Research of Rock Hill, Rock Hill, South Carolina, United States
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Nephron Pharmaceuticals Corporation
- Target Recruit Count
- 335
- Registration Number
- NCT02059278
© Copyright 2024. All Rights Reserved by MedPath